IMA vs SYK · rev $800.0K vs P/E 35, rev $6.59B
ImageneBio, Inc. (IMA) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
Latest reported IMA revenue for 2025-09-30 was $800.0K. Net income was -$38.4M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. IMA currently screens at market cap $64.7M.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
IMA currently screens at market cap $64.7M. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the IMA and SYK stock pages for the full models.
Not investment advice.